Skip to main content

Table 5 Median (range) bronchoalveolar lavage fluid (BALF) and serum levels (pg/ml) of the measured cytokines and adhesion molecules in at risk patients who developed or did not develop acute respiratory distress syndrome (groups B + C)

From: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome

 

BALF

Serum

 

Survivors (n = 27)

Non-survivors (n = 15)

Survivors (n = 27)

Non-survivors (n = 15)

IL-1

216 (0–860)

410 (0–630)

150 (3–306)

450** (400–563)

TNF-α

170 (0–680)

180 (0–481)

187 (94–775)

440* (170–1280)

sICAM-1

1250 (260–4620)

1860 (760–3780)

220 (66–360)

565** (350–900)

sVCAM

312 (136–792)

356 (52–924)

150 (66–310)

370** (300–720)

  1. * P < 0.01, ** P < 0.0001, versus survivors group. Comparisons were done using the Mann-Whitney test. IL-1 = interleukin-1; TNF-α = tumour necrosis factor-alpha; sICAM-1 = serumintercellular adhesion molecule-1; sVCAM = serum vascular adhesion molecule